Scholars@Duke

Gene Expression Profiling Reveals 5-Azacytidine to Be a Novel, Potentially Effective Therapy for Poor-Prognosis Patients with Multiple Myeloma

Publication ,  Conference
Tuchman, S; Acharya, C; Mostertz, W; Barry, W; Gasparetto, C; Barlogie, B; Potti, A; Shaughnessy, JD
Published in: BLOOD
November 20, 2009
Link to item

Duke Scholars

Cristina Gasparetto
Author Cristina Gasparetto Medicine, Hematologic Malignancies and Cellular Therapy

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 20, 2009

Volume

114

Issue

22

Start / End Page

728 / 728

Location

New Orleans, LA

Publisher

AMER SOC HEMATOLOGY

Conference Name

51st Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tuchman, S., Acharya, C., Mostertz, W., Barry, W., Gasparetto, C., Barlogie, B., … Shaughnessy, J. D. (2009). Gene Expression Profiling Reveals 5-Azacytidine to Be a Novel, Potentially Effective Therapy for Poor-Prognosis Patients with Multiple Myeloma. In BLOOD (Vol. 114, pp. 728–728). New Orleans, LA: AMER SOC HEMATOLOGY.
Tuchman, Sascha, Chaitanya Acharya, William Mostertz, William Barry, Cristina Gasparetto, Bart Barlogie, Anil Potti, and John D. Shaughnessy. “Gene Expression Profiling Reveals 5-Azacytidine to Be a Novel, Potentially Effective Therapy for Poor-Prognosis Patients with Multiple Myeloma.” In BLOOD, 114:728–728. AMER SOC HEMATOLOGY, 2009.
Tuchman S, Acharya C, Mostertz W, Barry W, Gasparetto C, Barlogie B, et al. Gene Expression Profiling Reveals 5-Azacytidine to Be a Novel, Potentially Effective Therapy for Poor-Prognosis Patients with Multiple Myeloma. In: BLOOD. AMER SOC HEMATOLOGY; 2009. p. 728–728.
Tuchman, Sascha, et al. “Gene Expression Profiling Reveals 5-Azacytidine to Be a Novel, Potentially Effective Therapy for Poor-Prognosis Patients with Multiple Myeloma.” BLOOD, vol. 114, no. 22, AMER SOC HEMATOLOGY, 2009, pp. 728–728.
Tuchman S, Acharya C, Mostertz W, Barry W, Gasparetto C, Barlogie B, Potti A, Shaughnessy JD. Gene Expression Profiling Reveals 5-Azacytidine to Be a Novel, Potentially Effective Therapy for Poor-Prognosis Patients with Multiple Myeloma. BLOOD. AMER SOC HEMATOLOGY; 2009. p. 728–728.

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 20, 2009

Volume

114

Issue

22

Start / End Page

728 / 728

Location

New Orleans, LA

Publisher

AMER SOC HEMATOLOGY

Conference Name

51st Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology